Investor Relations

Upcoming Events

Jun 7, 2023 • 10:00am CDT

William Blair 43rd Annual Growth Stock Conference

Latest Presentation

2023-05-04

Investor Presentation

Latest Financial Results

Q1 2023

Quarter Ended Mar 31, 2023

$72.2 Total first quarter revenue of $72.2 million in-line with company expectations
25.4% Q1 rental revenue grew 25.4% year-over-year
($11.8) Adjusted EBITDA loss of ($11.8) million slightly better than company expectations

For complete information regarding our financials, see our periodic filings

Sign up for Email Alerts

Give Me Alerts

Stock Information

Inogen, Inc.

About Inogen

Inogen is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.

View Company Profile

2022 Revenue Breakdown

2021 Revenue Breakdown

Products

Inogen One G5® product image

Inogen One G5®

  • 6 flow settings
  • 4.7 pounds
  • Battery life up to 13 hours
  • Technology clinically validated for 24/7 use
  • Meets FAA requirements
Inogen One G4® product image

Inogen One G4®

  • 3 flow settings
  • 2.8 pounds
  • Battery life up to 5 hours
  • Meets FAA requirements
  • Technology clinically validated for 24/7 use
Inogen At Home® product image

Inogen At Home®

  • 5 liters per minute, continuous flow
  • Only 18 pounds
  • Extremely quiet
  • Energy-efficient
  • Only 100W on Flow Setting 2

A Team Built for Success

Our leadership team is focused on strengthening the Inogen brand via expanding awareness of our innovative solutions as well as growing across our consumer and business sales channels.